Hims & Hers vs Ro

Side-by-side comparison of model-estimated upside.

Hims & Hers

+19%

est. 2Y upside i

Healthcare

Rank

#1499

Sector

Healthcare Providers & Services

Est. Liquidity

~1Y

Data Quality

Data: High

Hims & Hers offers a credible equity story anchored in 59% revenue growth, profitability, and 74% gross margins at a depressed 2.7x revenue multiple — meaningfully below where durable, profitable digital health platforms typically trade.

Last updated: May 5, 2026

Ro

-38%

est. 2Y upside i

HealthcareSeries D+

Rank

#3135

Sector

Healthcare

Est. Liquidity

~3Y

Data Quality

Data: Low

Ro's equity carries significant downside risk over a 2-year horizon due to a stale $7B valuation and likely multiple compression toward public comps.

Last updated: July 21, 2026

Note: These companies have different risk levels. Hims & Hers (Moderate Risk) and Ro (Higher Risk). A higher expected upside in a higher-risk company comes with greater uncertainty. Compare within the same risk tier for more meaningful evaluation.

Upside Comparison

Expected Upside

Hims & Hers
+19%
Ro
-38%

Disclaimer: These rankings are AI-generated estimates and do not constitute financial or career advice. Always conduct your own due diligence.